Envista to acquire Osteogenics Biomedical business

Envista Holdings Corporation has entered into a definitive agreement to acquire Osteogenics Biomedical Inc, Allotech LLC and OBI Biologics, Inc. The transaction is expected to close in the third quarter of 2022.

“Increasing our capabilities in regenerative solutions is consistent with our intention to digitize, personalize, and democratize oral care.”investors.envistaco.com

• 1 source
• investors.envistaco.comENVISTA TO ACQUIRE OSTEOGENICS BIOMEDICAL BUSINESS - May 17, 2022May 17, 2022

Summarized from public sources; check the original articles before acting on it.